Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
News|Videos|October 14, 2021
What keeps you up at night in ophthalmology: Part VII
Author(s)Alex Delaney-Gesing , David Hutton
Ophthalmologists and industry executives share what lingers on their minds at the end of the day.
Advertisement
Featured in this video, in order of appearance:
Steven Greenstein, MD; Cornea and Laser Institute (Teaneck, NJ)
Edward Holland, MD; chief medical advisor (Aurion Biotech)
George O. Waring, IV, MD; Waring Vision Institute (Mt. Pleasant, SC)
Cathleen McCabe, MD; The Eye Associates (FL)
Watch the previous installments in this series:
Advertisement
Related to this article
Dry eye cases rise with heavy screen use and younger patients; learn modern workups spotlighting MGD, etiology-driven treatments, and collaborative care reshaping outcomes.
Andrew G. Lee, MD, and Drew Carey, MD, discuss findings from a retrospective study examining ischemic stroke risk in patients with non-arteritic anterior ischemic optic neuropathy and the implications for vascular risk factor management.
Optometrist–ophthalmologist co-management targets dry eye early, improves cataract and refractive surgery satisfaction, and uses advanced diagnostics and treatments for healthier ocular surfaces.
Diana Canto-Sims, OD, owner of Buena Vista Optical, discusses how Meta's donation of free AI glasses to blind veterans could close longstanding access gaps in low vision care—and where voice-command wearables fit alongside traditional rehabilitation tools.
Their conversation covers a holistic, cross-specialty approach to ocular surface disease and the unmet need driving a new model of dry eye care in Ireland.
Douglas D. Koch, MD, and Karolinne Maia Rocha, MD, PhD, discuss the optics behind enhanced monofocal lenses, patient selection, and how to set expectations.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia
2
How Lambert-Eaton myasthenic syndrome presents around the eyes
3
The interplay between cardiac disease and the eye
4
City Therapeutics doses first participant in phase 1 trial of RNAi therapy CITY-RBP4 for Stargardt disease
5